SPHK2
Basic information
Region (hg38): 19:48619290-48630717
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPHK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 54 | 59 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 54 | 7 | 5 |
Variants in SPHK2
This is a list of pathogenic ClinVar variants found in the SPHK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-48620524-C-A | not specified | Uncertain significance (Dec 12, 2023) | ||
19-48620528-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
19-48625911-C-T | Likely benign (Nov 01, 2022) | |||
19-48625917-C-A | not specified | Uncertain significance (May 21, 2024) | ||
19-48625928-G-C | not specified | Uncertain significance (Jun 18, 2021) | ||
19-48625961-T-C | not specified | Uncertain significance (Apr 20, 2024) | ||
19-48625963-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
19-48625976-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
19-48625997-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
19-48626035-G-A | not specified | Uncertain significance (Feb 12, 2024) | ||
19-48626041-C-T | not specified | Uncertain significance (Jun 30, 2023) | ||
19-48626060-C-T | not specified | Uncertain significance (Jul 28, 2021) | ||
19-48626063-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
19-48626077-A-C | not specified | Uncertain significance (Jan 26, 2022) | ||
19-48626084-G-A | not specified | Uncertain significance (Jun 14, 2022) | ||
19-48626100-T-G | Likely benign (Mar 01, 2023) | |||
19-48626113-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
19-48626114-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
19-48626128-C-G | not specified | Uncertain significance (Apr 27, 2022) | ||
19-48626143-T-A | not specified | Uncertain significance (Nov 06, 2023) | ||
19-48626162-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
19-48626168-G-A | not specified | Uncertain significance (Nov 01, 2022) | ||
19-48626233-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
19-48626237-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
19-48626272-G-T | not specified | Uncertain significance (Feb 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPHK2 | protein_coding | protein_coding | ENST00000245222 | 6 | 11427 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.28e-7 | 0.821 | 125695 | 0 | 52 | 125747 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.32 | 358 | 435 | 0.823 | 0.0000306 | 4022 |
Missense in Polyphen | 98 | 146.79 | 0.6676 | 1308 | ||
Synonymous | -0.290 | 211 | 206 | 1.03 | 0.0000151 | 1564 |
Loss of Function | 1.48 | 14 | 21.4 | 0.655 | 0.00000126 | 198 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00105 | 0.00104 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000162 | 0.000139 |
European (Non-Finnish) | 0.000167 | 0.000158 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000270 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro- dihydrosphingosine, D-erythro-sphingosine and L-threo- dihydrosphingosine. Binds phosphoinositides. {ECO:0000269|PubMed:19168031}.;
- Pathway
- Fc gamma R-mediated phagocytosis - Homo sapiens (human);VEGF signaling pathway - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Apelin signaling pathway - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Gaucher Disease;Globoid Cell Leukodystrophy;Metachromatic Leukodystrophy (MLD);Fabry disease;Krabbe disease;Sphingolipid Metabolism;Signal Transduction of S1P Receptor;Metabolism of Spingolipids in ER and Golgi apparatus;Metabolism of lipids;Metabolism;Glycosphingolipid metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;sphingosine and sphingosine-1-phosphate metabolism;Sphingosine 1-phosphate (S1P) pathway;Ceramide signaling pathway;IL12-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- 0.795
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63.57
Haploinsufficiency Scores
- pHI
- 0.0898
- hipred
- N
- hipred_score
- 0.272
- ghis
- 0.479
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.996
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sphk2
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype; embryo phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- sphk2
- Affected structure
- median fin
- Phenotype tag
- abnormal
- Phenotype quality
- blistered
Gene ontology
- Biological process
- blood vessel development;sphingosine-1-phosphate receptor signaling pathway;sphinganine-1-phosphate biosynthetic process;brain development;female pregnancy;cell population proliferation;positive regulation of cell population proliferation;sphingolipid biosynthetic process;negative regulation of apoptotic process;sphingosine biosynthetic process;lipid phosphorylation
- Cellular component
- lysosomal membrane;cytosol;membrane;intracellular membrane-bounded organelle
- Molecular function
- NAD+ kinase activity;protein binding;ATP binding;sphinganine kinase activity;Ras GTPase binding;D-erythro-sphingosine kinase activity;sphingosine-1-phosphate receptor activity